THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Biogen enters agreement to acquire RayThera and advance immunology assets

Official image for Biogen enters agreement to acquire RayThera and advance immunology assets
Official collaboration image · verified from the named source

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Biogen and RayThera announced a definitive acquisition agreement under which Biogen would acquire RayThera’s immunology portfolio, with Biogen expected to lead development, manufacturing and global commercialization after closing.

Current status
Official collaboration
Known availability
The official source confirms the collaboration; timing details remain under review.
Place
Cambridge, Massachusetts; San Diego, California, United States
Source checked
September 9, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.